Help

BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Employee Benefits

Medicare spending on GLP-1 drugs skyrockets

March 27, 2024 Reprints

Medicare's total spending on GLP-1 drugs, originally developed for Type 2 diabetes but now popular for tackling obesity, surged from $57 million in 2018 to $5.7 billion in 2022, according to a KFF analysis, Becker’s Payer Issues reports. Despite Medicare not being allowed to cover these drugs for weight loss, they can be covered for other medically accepted indications, such as reducing cardiovascular risk.

1. Hackers leak stolen data from Change Healthcare on dark web
2. UnitedHealth estimates $1.6 billion loss from Change cyberattack
3. UnitedHealth reports significant data breach; personal health info compromised
4. Ex-NBA player Will Bynum sentenced in insurance fraud scandal
5. Illinois House passes governor’s 'Healthcare Protection Act’
6. Analyst says Cigna, Humana share prices could put merger back on the table

Help

Medicare spending on GLP-1 drugs skyrockets

Readers Poll

Most Read in Employee Benefits

Sign up now for free access to this article and much more.

If you are already registered with Business Insurance, click here to Login

Please tell us a bit more about yourself in order to continue

About

Advertise

Reprints and Licensing

Resources